Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
0.958
-0.062 (-6.12%)
At close: Feb 21, 2025, 4:00 PM
0.945
-0.013 (-1.32%)
After-hours: Feb 21, 2025, 7:56 PM EST
Alzamend Neuro Ratios and Metrics
Market cap in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
| Market Capitalization | 5 | 5 | 53 | 95 | - | - | |
| Market Cap Growth | -37.90% | -90.80% | -44.08% | - | - | - | |
| Enterprise Value | 1 | 5 | 46 | 83 | - | - | |
| Last Close Price | 0.96 | 7.11 | 82.09 | 153.00 | - | - | |
| PB Ratio | 1.33 | -1.88 | 17.42 | 7.11 | - | - | |
| P/TBV Ratio | 1.87 | - | 17.42 | 7.11 | - | - | |
| Debt / Equity Ratio | - | -0.12 | - | - | 0.17 | 0.08 | |
| Quick Ratio | 3.26 | 0.12 | 1.79 | 12.07 | 2.16 | 0.19 | |
| Current Ratio | 3.80 | 0.14 | 2.03 | 12.37 | 3.24 | 1.83 | |
| Return on Equity (ROE) | -1092.96% | -4408.31% | -181.47% | -160.92% | -356.06% | -774.66% | |
| Return on Assets (ROA) | -121.64% | -189.73% | -90.97% | -88.35% | -130.96% | -166.83% | |
| Return on Capital (ROIC) | -680.83% | -1651.80% | -113.36% | -98.09% | -191.48% | -431.84% | |
| Earnings Yield | -113.48% | -203.75% | -28.04% | -13.03% | - | - | |
| FCF Yield | -153.85% | -172.40% | -16.82% | -7.08% | - | - | |
| Buyback Yield / Dilution | -118.23% | -4.07% | -9.45% | -22.64% | -1.96% | -21.09% | |
| Total Shareholder Return | -118.23% | -4.07% | -9.45% | -22.64% | -1.96% | -21.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.